Sort
39,280 grants matching “leukemia”
Eastern Cooperative Oncology Group
$303,739Johns Hopkins University · U10 · FY2005 · CA
Structure-Function relationship of novel phosphoregulatory sites and effect of acute lymphoblastic leukemia SNPs on Jak3 activity: Implications for new cancer treatments
$303,737Robert Kirken · University Of Texas El Paso · U54 · FY2021 · MD
HEDGEHOG SIGNALING IN RESPONSE TO TISSUE INJURY AND IN NEOPLASIA
$303,730Philip A Beachy · Johns Hopkins University · P01 · FY2009 · CA
Molecular Genetic Basic of Cyclic Hematopiesis
$303,691Marshall S. Horwitz · University Of Washington · R01 · FY2011 · DK
PHARMACOLOGICAL MODULATION OF EPIGENETIC CHANTGES IN AML
$303,674Ohio State University · R01 · FY2005 · CA
PHARMACOLOGICAL MODULATION OF EPIGENETIC CHANGES IN AML
$303,674Ohio State University · R01 · FY2004 · CA
Polymorphism of Multi-Drug-Resistance Protein-1
$303,667University Of Washington · R01 · FY2002 · GM
NQO1 in Protection Against Benzene Toxicicity
$303,666University Of Colorado Denver · R01 · FY2003 · ES
Foamy Virus Vectors for Stem Cells
$303,656University Of Washington · P01 · FY2004 · HL
Biology of Tumor-Stroma Interaction
$303,635Leland W. Chung · Cedars-Sinai Medical Center · P01 · FY2009 · CA
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT
$303,626Michael R Bishop · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Understanding mechanisms of impaired immunity in the AML bone marrow
$303,621Susan E Dewolf · Sloan-Kettering Inst Can Research · K08 · FY2025 · CA
Understanding mechanisms of impaired immunity in the AML bone marrow
$303,621Susan E Dewolf · Sloan-Kettering Inst Can Research · K08 · FY2024 · CA
Improving therapy of glioblastoma multiforme by enhancing therapeutic drug delive
$303,614Michael R McDevitt · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
The Role Of CREB In Leukemogenesis
$303,589University Of California Los Angeles · R01 · FY2004 · HL
Regulatory mechanisms of the Crk Adapter protein
$303,564Charalampos Kalodimos · Rutgers The State Univ Of Nj Newark · R01 · FY2007 · GM
STRUCTURES OF ANTIBIOTICS AND RELATED COMPOUNDS
$303,530University Of Illinois Urbana-Champaign · R01 · FY2000 · GM
Targeting the Unfolded Protein Response in Leukemia Biology and Chemotherapy Resistance
$303,529Stephen Matthew Sykes · Washington University · R01 · FY2022 · CA
Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2
$303,525A Thomas Look · Dana-Farber Cancer Inst · R01 · FY2009 · CA
Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2
$303,525A Thomas Look · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Genetic Modifiers of the Anti-apoptotic Functions of Bcl-2
$303,525A Thomas Look · Dana-Farber Cancer Inst · R01 · FY2008 · CA
Turning off the molecular switch for pathological self-assembly of FUS
$303,484Nicolas Lux Fawzi · Brown University · R01 · FY2017 · GM
TRANSCRIPTION FACTOR MUTATIONS AND HUMAN AML
$303,476Beth Israel Deaconess Medical Center · R01 · FY2001 · CA
Functions of Ub-like Proteins &Processing Proteases
$303,475Emory University · R01 · FY2002 · GM
COGNITIVE BEHAVIORAL ASPECTS OF CANCER RELATED FATIGUE
$303,439University Of South Florida · R01 · FY2001 · CA